Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

Healthcare professionals are increasingly recognizing peer support as a valuable element of diabetes care; read for a list of peer support communities
App allows FreeStyle Libre sensor users to monitor blood sugar on their smartphone without a separate reader. Tools also available for sharing glucose data with...
Limited launch in May-July. No receiver! Smartphone-only display on Apple iOS devices. Plus, the new “personal diabetes assistant,” Sugar.IQ with Watson
Admelog will launch this year as the first approved biosimilar rapid-acting insulin. Will it be less expensive than Humalog?
A restaurant mistake and four lessons I’m taking away from it…
How you can get a copy of Bright Spots & Landmines: The Diabetes Guide I Wish Someone Had Handed Me.
Called “Insulin Lispro,” the generic version of Humalog may benefit those paying cash or with high-deductible health plans
Surprising study findings from a look at refrigerator temperatures and the risk posed to insulin quality; plus, a guide to safe insulin storage and Med Angel’s very cool...
The importance of sleep for teens with diabetes. Plus, key sleep strategies from young adults living with diabetes!
New product details, pictures, and study timing updates on Beta Bionics’ iLet and Bigfoot’s Loop and Inject systems from Friends for Life 2018
News from Onduo's virtual diabetes clinic, Klue, SugarMate, and Diabits apps, Tidepool Loop, and more!
Data on type 2 diabetes therapies and prevention, Medtronic MiniMed 780G trial starts, Beta Bionics Gen 3 iLet time-in-range results, and more!
Control-IQ hybrid closed loop coming in summer 2019; paired app coming soon to the US; plans for the t:sport “patch” pump; and t:slim X2 pump launched outside the US
Updates to the Clarity app allow G5 and G6 CGM users to set a daily time-in-range goal and be notified when it is reached, awesome Bright Spots pattern recognition in...
A new study will investigate whether SGLT-2 inhibitor Farxiga can delay the progression of heart failure in people with and without type 2 diabetes
A new online resource for people with type 2 diabetes offers a place to share stories, get connected, and learn tips for day-to-day management – BeyondType2.org
First drug trial to show delay in type 1 diagnoses, heart and kidney benefits from Trulicity in type 2, huge focus on time-in-range, positive results for both Tandem’s...
An inside look into former Aetna CEO Mark Bertolini's book, "Mission Driven Leadership: My Journey as a Radical Capitalist"
AgaMatrix blood glucose meters and strips by Amazon could make ordering diabetes supplies more convenient and cheaper
The latest updates on time-in-range goals for people with all types of diabetes, and insights linking FreeStyle Libre scanning frequency to outcomes.

Pages